Accelerate Diagnostics, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
CEO Jack Phillips of Accelerate Diagnostics reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Chief Financial Officer of Accelerate Diagnostics, David Patience, reports the acquisition and disposal of company stock and restricted stock units on April 1, 2025.
David Patience, CFO of Accelerate Diagnostics, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
CEO Jack Phillips of Accelerate Diagnostics reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Form 4: Accelerate Diagnostics Director John Patience Acquires 200,000 Shares in Private Transaction
Director John Patience of Accelerate Diagnostics, Inc. purchased 200,000 shares of common stock in a private transaction on December 3, 2024.
Director Jack W. Schuler sold 200,000 shares of Accelerate Diagnostics stock in a private transaction for tax planning purposes.
Director Hany Massarany reports exercising stock options and changes in beneficial ownership of Accelerate Diagnostics, Inc. shares.
Director Louise Francesconi reported the vesting of restricted stock units in Accelerate Diagnostics, Inc. on June 28, 2024.
Director Jack W. Schuler reports a transaction involving Accelerate Diagnostics, Inc. stock, including the vesting of restricted stock units.
Director Wayne Burris exercised stock options in Accelerate Diagnostics, Inc., acquiring 839 shares of common stock on May 31, 2024.
Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, Inc., was granted 120,000 restricted stock units on May 29, 2024.
Director Louise Francesconi reports the vesting and subsequent disposal of restricted stock units in Accelerate Diagnostics.
Director Jennifer Regan reports vesting of restricted stock units in Accelerate Diagnostics, Inc.
Director Jack W. Schuler exercised stock options and disposed of restricted stock units in Accelerate Diagnostics, Inc.
CEO Jack Phillips of Accelerate Diagnostics, Inc. was granted 360,000 restricted stock units (RSUs) on May 29, 2024, according to a recent SEC Form 4 filing.
Director Hany Massarany reports the vesting of restricted stock units into common stock of Accelerate Diagnostics.
David Patience, CFO of Accelerate Diagnostics, was granted 120,000 restricted stock units (RSUs) on May 29, 2024, according to a Form 4 filing with the SEC.
Jack Schuler, a director and 10% owner of Accelerate Diagnostics, acquired 1,560,694 units, each consisting of one share of common stock and one warrant, in a private placement.
Form 4: Director Wayne Burris Receives 66,667 Restricted Stock Units in Accelerate Diagnostics, Inc.
Wayne Burris, a director of Accelerate Diagnostics, Inc., was granted 66,667 restricted stock units (RSUs) on May 20, 2024, which vest on the first anniversary of the grant date.
Director Marran H. Ogilvie of Accelerate Diagnostics, Inc. was granted 66,667 restricted stock units (RSUs) on May 20, 2024, which vest on the first anniversary of the grant date, with deferred receipt of shares until departure from the board.
Director Mark S. Black of Accelerate Diagnostics, Inc. was granted 66,667 restricted stock units (RSUs) on May 20, 2024, which vest on the first anniversary of the grant date, with deferred receipt of shares until departure from the board.
Director Louise Francesconi was granted 66,667 restricted stock units (RSUs) in Accelerate Diagnostics, Inc. on May 20, 2024, according to a Form 4 filing.
Larry Mertz, Chief Technology Officer of Accelerate Diagnostics, reports the vesting and sale of restricted stock units to cover tax obligations.
Director John Patience acquired 66,667 Restricted Stock Units (RSUs) in Accelerate Diagnostics on May 20, 2024, which vest on the first anniversary of the grant date.
Director Jennifer Regan was granted 66,667 restricted stock units (RSUs) in Accelerate Diagnostics, Inc. on May 20, 2024, which vest on the first anniversary of the grant date.
Director Jack W. Schuler acquired 66,667 restricted stock units in Accelerate Diagnostics, Inc. on May 20, 2024, which vest on the first-year anniversary of the grant date.
Form 4: Accelerate Diagnostics Director Hany Massarany Reports Acquisition of Restricted Stock Units
Director Hany Massarany reports acquisition of 66,667 Restricted Stock Units (RSUs) in Accelerate Diagnostics, Inc.
CEO Jack Phillips of Accelerate Diagnostics, Inc. reports the acquisition and disposal of company stock related to the vesting of restricted stock units (RSUs) to cover tax obligations.
CEO Jack Phillips of Accelerate Diagnostics exercised stock options and sold shares to cover tax obligations related to vesting restricted stock units.